This report was sent to Briefing.com subscribers earlier today.
Research calls posted earlier this morning are available here.
Upgrades:
> Alamo Group (ALG) upgraded to Buy from Neutral at DA Davidson; tgt raised to $196
> Block (SQ) upgraded to Buy from Neutral at Mizuho; tgt raised to $93
> Deutsche Boerse (DBOEY) upgraded to Outperform from Neutral at Credit Suisse
> HF Sinclair (DINO) upgraded to Overweight from Equal Weight at Wells Fargo; tgt $55
> LexinFintech (LX) upgraded to Buy from Accumulate at CLSA; tgt $3.45
> On (ONON) upgraded to Outperform from Neutral at Wedbush; tgt raised to $25
> Progressive (PGR) upgraded to Overweight from Underweight at Wells Fargo; tgt raised to $158
> TPI Composites (TPIC) upgraded to Buy from Neutral at Guggenheim; tgt $22
> UiPath (PATH) upgraded to Buy from Hold at Canaccord Genuity; tgt raised to $19
> Under Armour (UAA) upgraded to Buy from Hold at Williams Trading; tgt $11
Downgrades:
> Halozyme Therapeutics (HALO) downgraded to Market Perform from Outperform at SVB Securities; tgt $42
> Kezar Life Sciences (KZR) downgraded to Mkt Perform from Outperform at William Blair
> LivePerson (LPSN) downgraded to Hold from Buy at Craig Hallum; tgt lowered to $6
> Man Group (MNGPF) downgraded to Neutral from Outperform at Exane BNP Paribas
> Millicom International Cellular (TIGO) downgraded to Neutral from Overweight at JP Morgan
> Mytheresa (MYTE) downgraded to Market Perform from Outperform at TD Cowen; tgt lowered to $7
> Olaplex (OLPX) downgraded to Market Perform from Outperform at TD Cowen; tgt lowered to $4.50
Others:
> Cerevel Therapeutics (CERE) resumed with a Hold at Berenberg; tgt $22
> Inc. (EHAB) initiated with a Neutral at Goldman; tgt $15
> Global Net Lease (GNL) initiated with an Underperform at Exane BNP Paribas; tgt $13
> Intuit (INTU) initiated with a Neutral at UBS; tgt $430
> Safehold (SAFE) initiated with an Outperform at Exane BNP Paribas
> Samsara (IOT) initiated with a Neutral at Piper Sandler; tgt $21
> StoneCo (STNE) removed from Tactical Outperform List at Evercore ISI
> Theseus Pharmaceuticals (THRX) initiated with a Buy at Stifel; tgt $24
Sponsored: Find a Qualified Financial Advisor
Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to 3 fiduciary financial advisors in your area in 5 minutes. Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests. If you’re ready to be matched with local advisors that can help you achieve your financial goals, get started now.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Editors' Picks
